FDA approves Vertex and CRISPR Therapeutics’ CASGEVY for sickle cell disease

Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics have announced a significant milestone in medical science with the U.S. Food and Drug Administration's (FDA) approval of CASGEVY ... Read More